Angelman Syndrome clinical trials at University of California Health
3 in progress, 1 open to eligible people
Angelman Syndrome Natural History Study
open to all eligible people
The goal of this study is to conduct a prospective, longitudinal natural history study of children and adults with Angelman Syndrome using investigator-observed and parent-reported outcome measures to obtain data that will be useful for future clinical trials.
at UCSD
Long-term Extension of GTX-102 in Angelman Syndrome
Sorry, accepting new patients by invitation only
The primary objective of the study is to evaluate the long-term safety profile of GTX-102 in participants with Angelman Syndrome (AS)
at UCLA UCSD
GTX-102 in Pediatric Subjects With Angelman Syndrome (AS)
Sorry, in progress, not accepting new patients
The primary objective of this study is to evaluate the effect of GTX-102 in cognitive function in participants with deletion-type Angelman Syndrome (AS).
at UCSD UCSF
Our lead scientists for Angelman Syndrome research studies include Rajsekar R. Rajaraman, MD, MS.
Last updated: